Law / United States / 
Texas
Texas Genomic Act of 2025
Officially Texas Genomic Act: ban on genome sequencers and software produced by or for a foreign adversary
Tex. Health & Safety Code secs. 174.003, 174.005
In force since .
A sensitive categories rule binding public and private bodies.
- Obligation class
- Prohibition, Reporting
- Audit expectation
- none
As of .
What it requires
- If you are a medical facility, research facility, company or nonprofit organization that conducts research on or testing of genome sequencing or the human genome in Texas, do not use a genome sequencer or software produced by or on behalf of a foreign adversary, a state-owned enterprise of a foreign adversary, an organization domiciled in a country that is a foreign adversary, or an owned or controlled subsidiary or affiliate of such an organization (Tex. Health & Safety Code secs. 174.003, 174.005).
- Certify to the attorney general not later than December 31 of each year that you are in compliance with chapter 174, through an attorney who submits the certification where one represents you (Tex. Health & Safety Code sec. 174.008).
These lines are LexLint's reading of the law's text, as of .
If you get it wrong
Penalty structure
Tex. Health & Safety Code sec. 174.010: a medical facility, research facility, company or nonprofit organization that violates chapter 174 is liable to this state for a civil penalty of $10,000 for each violation, which the attorney general may bring an action to recover.
- Rule
- Per violation only
- As of
- Currency
- USD
- Per violation unit
- Violation
- Per violation amount
- 10,000
Who enforces it
Enforcement body
Texas attorney general, who may bring an action to recover the civil penalty (Tex. Health & Safety Code sec. 174.010(b)).
What this law does
Chapter 174 may be cited as the Texas Genomic Act of 2025. Chapter 174 applies to a medical facility, research facility, company or nonprofit organization that conducts research on or testing of genome sequencing or the human genome in this state.
A medical facility, research facility, company or nonprofit organization subject to chapter 174 may not use a genome sequencer or software produced by or on behalf of a foreign adversary, a state-owned enterprise of a foreign adversary, a company or nonprofit organization domiciled in a foreign adversary country, or an owned or controlled subsidiary or affiliate of such an organization.
A covered facility, company or organization must certify to the attorney general not later than December 31 of each year that it is in compliance with chapter 174. The attorney general may investigate an allegation of a violation of chapter 174. A medical facility, research facility, company or nonprofit organization that violates chapter 174 is liable to this state for a civil penalty of $10,000 for each violation, which the attorney general may bring an action to recover. Chapter 174 was added by Acts 2025, 89th Legislature, chapter 368 (House Bill 130), effective .
When LexLint raises it
When your app profile says your app processes biometric data.